𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The invisibility of science publications in hebrew: A comparative database study

✍ Scribed by Avishag Gordon


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
92 KB
Volume
63
Category
Article
ISSN
1532-2882

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Since the end of World War II, the English language has become the lingua franca of science publications worldwide. Science publications written in other languages do not gain the same exposure to the international scientific community as does the material in English. In this sense, non‐English articles constitute an β€œinvisible science” for the rest of the scientific world. This study compares publications indexed in the academic‐oriented Hebrew Index of Periodicals (IHP) database with those in the Science Citation Index Expanded (SCIE) in order to document the amount of scientific material published in Israel, where Hebrew is the native language. Except for abstracts, which are sometimes given in English, as well as Hebrew, and therefore provide some idea of a paper's content, most of this research remains hidden from the international scientific community. The SCIE and IHP databases for our examination cover the three grand disciplines: the exact and life sciences, the social sciences, and the humanities. Additionally, the study probes the coverage of medical publications in the two databases. The difference between old and emerging disciplines in the use of a language other than Hebrew is observed and non‐English citation patterns for various disciplines are examined. The results confirm the dominance of English as the lingua franca of science and point to the large number of scientific studies in Hebrew that lack international exposure.


πŸ“œ SIMILAR VOLUMES


Adverse drug reactions to dopamine agoni
✍ Santiago Perez-Lloret; Emmanuelle Bondon-Guitton; Olivier Rascol; Jean-Louis Mon πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 71 KB

## Abstract Pharmacodynamical differences between dopamine agonists (DAs) suggest differences in their adverse drug reactions (ADRs) profile. In this study, frequencies of ADR to DAs or levodopa reports in the French Pharmacovigilance Database were explored. Reports occurring between January 1, 198